Cargando…
METTL3 promotes adriamycin resistance in MCF-7 breast cancer cells by accelerating pri-microRNA-221-3p maturation in a m6A-dependent manner
Breast cancer (BC) is the most prevalent malignant neoplasm among women and is the fifth most common cause of cancer-associated death worldwide. Acquired chemoresistance driven by genetic and epigenetic alterations is a significant clinical challenge in treating BC. However, the mechanism of BC cell...
Autores principales: | Pan, Xiaoping, Hong, Xiaolv, Li, Sumei, Meng, Ping, Xiao, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080609/ https://www.ncbi.nlm.nih.gov/pubmed/33420414 http://dx.doi.org/10.1038/s12276-020-00510-w |
Ejemplares similares
-
Exosomal MicroRNA-221-3p Confers Adriamycin Resistance in Breast Cancer Cells by Targeting PIK3R1
por: Pan, Xiaoping, et al.
Publicado: (2020) -
METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner
por: Han, Jie, et al.
Publicado: (2019) -
METTL3 mediates Ang-II-induced cardiac hypertrophy through accelerating pri-miR-221/222 maturation in an m6A-dependent manner
por: Zhang, Rui, et al.
Publicado: (2022) -
METTL3 promotes colorectal cancer metastasis by promoting the maturation of pri-microRNA-196b
por: Huang, Lanlan, et al.
Publicado: (2022) -
METTL3 promotes the initiation and metastasis of ovarian cancer by inhibiting CCNG2 expression via promoting the maturation of pri-microRNA-1246
por: Bi, Xuehan, et al.
Publicado: (2021)